Ironwood Pharmaceuticals inc (IRWD) - News Archive

Showing 2 of 2 results.

Ironwood Pharmaceuticals Reveals Positive Results for Apraglutide in Phase III Trial for Short Bowel Syndrome at DDW 2024

Ironwood Pharmaceuticals to Present Positive Data for Apraglutide in Short Bowel Syndrome at Digestive Disease Week 2024Ironwood Pharmaceuticals, a leading gastrointestinal-focused healthcare company, is set to present...

May 21, 2024 • Major Pharmaceutical Preparations Industry Business Update Nasdaq

Novel Insights into the Efficacy of Apraglutide on Short Bowel Syndrome with Intestinal Failure: An In-Depth Analysis of Ironwood Pharmaceuticals' Recent Clinical Findings

Ironwood Pharmaceuticals, Inc., a leading healthcare company with a primary focus on gastrointestinal (GI) disorders, is at the forefront of advancements in treatments for short bowel syndrome with intestinal failure (S...

May 1, 2024 • Major Pharmaceutical Preparations Industry Business Update Nasdaq